Biological and clinical aspects of soluble transferrin receptor

References

• Kohgo Y, Niitsu Y, Kondo H, Kato J, Tsushima N, Sasaki K, Hirayama M, Numata T, Nishisato T, Urushizaki I. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987; 70: 1955–1958.
   PubMed Web of Science ®Google Scholar
• Feelders RA, Kuiper-Kramer EP, van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med 1999; 37: 1–10.
   Google Scholar
• Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990; 75: 102–107.
   PubMed Web of Science ®Google Scholar
• Hayes GR, Enns CA, Lucas JJ. Identification of the O-linked glycosylation site of the human transferrin receptor. Glycobiology 1992; 2: 355–359.
   Google Scholar
• Williams AM, Enns CA. A mutated transferrin receptor lacking asparagine-linked glycosylation sites shows reduced functionality and an association with binding immunoglobulin protein. J Biol Chem 1991; 266: 17648–17654.
   Google Scholar
• Rutledge EA, Root BJ, Lucas JJ, Enns CA. Elimination of the O-linked glycosylation site at Thr 104 results in the generation of a soluble human-transferrin receptor. Blood 1994; 83: 580–586.
   Google Scholar
• Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 1999; 31: 1111–1137.
   PubMed Web of Science ®Google Scholar
• Pan BT, Blostein R, Johnstone RM. Loss of the transferrin receptor during the maturation of sheep reticulocytes in vitro. An immunological approach. Biochem J 1983; 210: 37–47.
   Web of Science ®Google Scholar
• Kühn JC, McClelland A, Ruddle FH. Gene transfer, expression and molecular cloning of the human transferrin receptor gene. Cell 1984; 37: 95–103.
   PubMed Web of Science ®Google Scholar
• Enns CA, Soumalainen HA, Gebhardt JE, Schroder J, Sussman J. Human transferrin receptor: expression of the receptor is assigned to chromosome 3. Proc Natl Acad Sci USA 1982: 79: 3241–3245.
   PubMed Web of Science ®Google Scholar
• Goodfellow PN, Banting G, Sutherland R, Greaves M, Solomon E, Poveys S. Expression of human transferrin receptor is controlled by a gene on chromosome 3: assignment using species specificity of a monoclonal antibody. Somatic Cell Genet 1982; 8: 197–206.
   Google Scholar
• Miller YE, Jones C, Scoggin C, Morse H, Seligman P. Chromosome 3q (22-ter) encodes the human transferrin receptor. Am J Hum Genet 1983; 35: 573–583.
   PubMed Web of Science ®Google Scholar
• Schneider C, Owen MJ, Banville D, Williams JG. Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature 1984; 311: 675–678.
   PubMed Web of Science ®Google Scholar
• Owen D, Kühn LC. Noncoding 3′ sequences of the transferrin receptor gene are required for mRNA regulation by iron. EMBO J 1987; 6: 1287–1293.
   PubMed Web of Science ®Google Scholar
• Evans P, Kemp J. Exon/intron structure of the human transferrin receptor gene. Gene 1997; 199: 123–131.
   Google Scholar
• Israeli RS, Powell CT, Fair WR, Heston WD. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993; 53: 227–230.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, Koeffler HP. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274: 20826–20832.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, Koeffler HP. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. Blood 2001; 98: 2714–2719.
   PubMed Web of Science ®Google Scholar
• Fleming RE, Migas MC, Holden CC, Waheed A, Britton RS, Tomatsu S, Bacon BR, Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary haemochromatosis. Proc Natl Acad Sci USA 2000; 97: 2214–2219.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Germain RS, Ikezoe T, Tong X, Green EM, Gombart AF, Koeffler HP. Regulation of expression of murine transferrin receptor 2. Blood 2001; 98: 1949–1954.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Germain RS, Vuong PT, Nakamaki T, Said JW, Koeffler HP. Transferrin receptor 2 supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem 2000; 275: 16618–16625.
   PubMed Web of Science ®Google Scholar
• West AP Jr, Bennett MJ, Sellers VM, Andrews NC, Enns CA, Bjorkman PJ. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 2000; 275: 38135–38138.
   Google Scholar
• Trinder D, Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 2003; 35: 292–296.
   PubMed Web of Science ®Google Scholar
• Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, Calì A, De Gobbi M, Gasparini P, Camaschella C. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001; 97: 2555–2560.
   PubMed Web of Science ®Google Scholar
• Camaschella C, Roetto A, Calì A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P. The gene TfR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000; 25: 14–15.
   PubMed Web of Science ®Google Scholar
• Girelli D, Bozzini C, Roetto A, Alberti F, Daraio F, Colombari R, Olivieri O, Corrocher R, Camaschella C. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology 2002; 122: 1295–1302.
   PubMed Web of Science ®Google Scholar
• Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003; 329: 9–22.
   PubMed Web of Science ®Google Scholar
• Omary MB, Trowbridge IS. Biosynthesis of the human transferrin receptor in cultured cells. J Biol Chem 1981; 256: 12888–12892.
   PubMed Web of Science ®Google Scholar
• Ahn J, Johnstone RM. Origin of a soluble truncated transferrin receptor. Blood 1993; 81: 2442–2451.
   Google Scholar
• Johnstone RM. Cleavage of the transferrin receptor by human granulocytes: differential proteolysis of the exosome-bound TFR. J Cell Physiol 1996; 168: 333–345.
   PubMedGoogle Scholar
• Grosbois B, Decaux O, Cador B, Cazalets C, Jego P. Human iron deficiency. Bull Acad Natl Med 2005; 189: 1649–1663; discussion 1663–1664.
   PubMed Web of Science ®Google Scholar
• Mast AE, Blinder MA, Gronowaki AM, Chumley C, Scott MG. Clinical utility of soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998; 44: 45–51.
   PubMed Web of Science ®Google Scholar
• Halbrooks PJ, He QY, Briggs SK, Everse SJ, Smith VC, MacGillivray RT, Mason AB. Investigation of the mechanism of iron release from the C-lobe of human serum transferrin: mutational analysis of the role of a pH sensitive triad. Biochemistry 2003; 42: 3701–3707.
   Google Scholar
• Williams J, Moreton K. The distribution of iron between the metal-binding sites of transferrin human serum. Biochem J 1980; 185: 483–488.
   PubMed Web of Science ®Google Scholar
• Mason AB, Halbrooks PJ, James NG, Connolly SA, Larouche JR, Smith VC, MacGillivray RT, Chasteen ND. Mutational analysis of C-lobe ligands of human serum transferrin: insights into the mechanism of iron release. Biochemistry 2005; 44: 8013–8021.
   Google Scholar
• Melefors Ö, Hentze MW. Iron regulatory factor. The conductor of cellular iron regulation. Blood Rev 1993; 7: 251–258.
   PubMed Web of Science ®Google Scholar
• Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, Harford JB. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 1988; 240: 924–928.
   PubMed Web of Science ®Google Scholar
• Hentze MW, Rouault TA, Caughman SW, Dancis A, Harford JB, Klausner RD. A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. Proc Natl Acad Sci USA 1987; 84: 6730–6734.
   PubMed Web of Science ®Google Scholar
• Müllner EW, Neupert B, Kuhn LC. A specific mRNA binding factor regulates the iron dependent stability of cytoplasmic transferrin receptor mRNA. Cell 1989; 58: 373–382.
   PubMed Web of Science ®Google Scholar
• Sawyer ST, Krantz SB. Transferrin receptor number, synthesis and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. J Biol Chem 1988; 261: 9187–9195.
   Google Scholar
• Weiss G, Houston T, Kastner S, Johrer K, Grunewald K, Brock JH. Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells. Blood 1997; 89: 680–687.
   PubMed Web of Science ®Google Scholar
• Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007; 370: 511–520.
   PubMed Web of Science ®Google Scholar
• Thorpe SJ, Heath A, Sharp G, Cook J, Ellis R, Worwood M. A WHO reference reagent for the serum transferrin receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation. Clin Chem Lab Med 2010; 48: 815–820.
   Google Scholar
• Vernet M, Doyen C. Assessment of iron status with a new fully automated assay for transferrin receptor in human serum. Clin Chem Lab Med 2000; 38: 437–442.
   Google Scholar
• Kohgo Y, Nishisato T, Kondo H, Tsushima N, Niitsu Y, Urushizaki I. Circulating transferrin receptor in human serum. Br J Haematol 1986; 64: 277–281.
   PubMed Web of Science ®Google Scholar
• Byrne SL, Mason AB. Human serum transferrin: a tale of two lobes. Urea gel and steady state fluorescence analysis of recombinant transferrins as a function of pH, time, and the soluble portion of the transferrin receptor. J Biol Inorg Chem 2009; 14: 771–781.
   Google Scholar
• Suominen P, Punnonen K, Rajamäki A, Irjala K. Evaluation of new immunoenzymometric assay for measuring soluble transferrin receptor to detect iron deficiency in anemic patients. Clin Chem 1997; 43: 1641–1646.
   PubMed Web of Science ®Google Scholar
• Akesson A, Bjellerup P, Vahter M. Evaluation of kits for measurement of the soluble transferrin receptor. Scand J Clin Lab Invest 1999; 59: 77–81.
   PubMed Web of Science ®Google Scholar
• Wians FH Jr, Urban JE, Kroft SH, Keffer JH. Soluble transferrin receptor (sTfR) concentration quantified using two sTfR kits: analytical and clinical performance characteristics. Clin Chim Acta 2001; 303: 75–81.
   Google Scholar
• Flowers CH, Skikne BS, Covell AM, Cook JD. The clinical measurement of serum transferrin receptor. J Lab Clin Med 1989; 114: 368–377.
   PubMed Web of Science ®Google Scholar
• Kuiper-Kramer EP, Huisman CM, van Raan J, van Eijk HG. Analytical and clinical implications of soluble transferrin receptors in serum. Eur J Clin Chem Clin Biochem 1996; 34: 645–649.
   PubMedGoogle Scholar
• Worwood M. Serum transferrin receptor assays and their application. Ann Clin Biochem 2002; 39: 221–230.
   Google Scholar
• Kuiper-Kramer EPA, van Raan J, van Eijk HG. A new assay for soluble transferrin receptors in serum: time for standardisation. Eur J Clin Chem Clin Biochem 1997; 35: 793.
   Google Scholar
• Allen J, Backstrom KR, Cooper JA, Cooper MC, Detwiler TC, Essex DW, Fritz RP, Means RT Jr, Meier PB, Pearlman SR, Roitman-Johnson B, Seligman PA. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem 1998; 44: 35–39.
   Google Scholar
• Kuiper-Kramer EPA, Baerts W, Bakker R, van Eyck J, van Raan J, van Eijk HG. Evaluation of the iron status of the newborn by soluble transferrin receptors in serum. Clin Chem Lab Med 1998; 36: 17–21.
   Google Scholar
• Hemmilä I. Fluoroimmunoassays and immunofluorometric assays. Clin Chem 1985; 31: 359–370.
   PubMed Web of Science ®Google Scholar
• Kivivuori SM, Anttila R, Viinikka L, Pesonen K, Siimes MA. Serum transferrin receptor for assessment of iron status in healthy prepubertal and early pubertal boys. Pediatr Res 1993; 34: 297–299.
   Google Scholar
• Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993; 81: 1067–1076.
   PubMed Web of Science ®Google Scholar
• Kogan AE, Filatov VL, Kara AN, Levina AA, Katrukha AG. Comparison of soluble and placental transferrin receptors as standards for the determination of soluble transferrin receptor in humans. Int J Lab Hematol 2007; 29: 335–340.
   Google Scholar
• Turkewitz AP, Amatruda JF, Borhani D, Harrison SC, Schwartz AL. A high-yield purification of the human transferrin receptor and properties of its major extracellular fragment. J Biol Chem 1988; 263: 8318–8325.
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, Scharpé S, Hendriks D, Cooremans W, Neels H, De Meyer F, D’Hondt P, Peeters D. Components of biological variation in serum soluble transferrin receptor: relationships to serum iron, transferrin and ferritin concentrations, and immune and haematological variables. Scand J Clin Lab Invest 1997; 57: 31–41.
   PubMed Web of Science ®Google Scholar
• Neckers LM, Cossman J. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and is regulated by interleukin-2. Proc Natl Acad Sci USA 1983; 89: 3494–3498.
   Google Scholar
• Kolbe-Busch S, Lotz J, Hafner G, Blanckaert NJ, Claeys G, Togni G, Carlsen J, Röddiger R, Thomas L. Multicenter evaluation of a fully mechanized soluble transferrin receptor assay on the Hitachi and cobas integra analyzers. The determination of reference ranges. Clin Chem Lab Med 2002; 40: 529–536.
   Google Scholar
• West AP Jr, Giannetti AM, Herr AB, Bennett MJ, Nangiana JS, Pierce JR, Weiner LP, Snow PM, Bjorkman PJ. Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J Mol Biol 2001; 313: 385–397.
   Google Scholar
• Lebrón JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998; 93: 111–123.
   PubMed Web of Science ®Google Scholar
• Gianetti AM, Bjorkman PJ. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface. J Biol Chem 2004; 279: 25866–25875.
   Google Scholar
• Roy CN, Penny DM, Feder JN, Enns CA. The hereditary hemochromatosis protein, HFE, specifically regulates transferrin mediated iron uptake in HeLa cells. J Biol Chem 1999; 274: 9022–9028.
   PubMedGoogle Scholar
• Jouanolle AM, Fergelot P, Gandon G, Yaouanq J, Le Gall JY, David V. A candidate gene for hemochromatosis: frequency of the C282Yand H63D mutations. Hum Genet 1997; 100: 544–547.
   PubMedGoogle Scholar
• Bérez V, Camps J, Arija V, Aranda N, Fernández-Ballart J, Vilella E, Figuera L, Ferré N, Joven J. Soluble transferrin receptor and mutations in hemochromatosis and transferrin genes in a general Catalan population. Clin Chim Acta 2005;353: 205–208.
   Google Scholar
• Hussain RI, Ballard CG, Edwardson JA, Morris CM. Transferrin gene polymorphism in Alzheimer’s disease and dementia with Lewy bodies in humans. Neurosci Lett 2002; 317: 13–16.
   PubMed Web of Science ®Google Scholar
• Namekata K, Oyama F, Imagawa M, Ihara Y. Human transferrin (Tf): a single mutation at codon 570 determines TfC1 or TfC2 variant. Hum Genet 1997; 100: 457–458.
   Google Scholar
• Hikawa A, Nomata Y, Suzuki T, Ozasa H, Yamada O. Soluble transferrin receptor-transferrin complex in serum: measurement by latex agglutination nephelometric immunoassay. Clin Chim Acta 1996; 254: 159–172.
   Google Scholar
• Pfeiffer CM, Cook JD, Mei Z, Cogswell ME, Looker AC, Lacher DA. Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin Chim Acta 2007; 382: 112–116.
   PubMed Web of Science ®Google Scholar
• Kaup M, Dassler K, Weise C, Fuchs H. Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2. J Biol Chem 2002; 277: 38494–38502.
   PubMedGoogle Scholar
• Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48: 1066–1076.
   PubMed Web of Science ®Google Scholar
• Sears D. Anemia of chronic disease. Med Clin North Am 1992; 76: 567–579.
   PubMed Web of Science ®Google Scholar
• Spivak JL. The blood in systemic disorders. Lancet 2000; 355: 1707–1712.
   PubMed Web of Science ®Google Scholar
• Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: abnormal behaviour in idiopathic hemochromatosis and in inflammation. Blood 1989; 74: 844–851.
   PubMed Web of Science ®Google Scholar
• Lulla RR, Thompson AA, Liem RI. Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric sickle cell disease. Pediatr Blood Cancer 2010; 55: 141–144.
   Web of Science ®Google Scholar
• Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89: 1052–1057.
   PubMed Web of Science ®Google Scholar
• WHO/UNICEF/UNU. Iron Deficiency Anaemia: Assessment, Prevention, and Control. A Guide for Programme Managers. Geneva: World Health Organization, 2001: 1–114.
   Google Scholar
• Choi JW, Kim CS, Pai SH. Erythropoietic activity and soluble transferrin receptor level in neonates and maternal blood. Acta Paediatr 2000; 89: 675–679.
   PubMed Web of Science ®Google Scholar
• Kuiper-Kramer EP, Coenen JL, Huisman CM, Abbes A, van Raan J, van Eijk HG. Relationship between soluble transferrin receptors in serum and membrane-bound transferrin receptors. Acta Haematol 1998; 99: 8–11.
   Google Scholar
• Hay G, Refsum H, Whitelaw A, Melbye EL, Haug E, Borch-Iohnsen B. Predictors of serum ferritin and serum soluble transferrin receptor in newborns and their associations with iron status during the first 2 y of life. Am J Clin Nutr 2007; 86: 64–73.
   Google Scholar
• Choi JW, Pai SH, Im MW, Kim SK. Change in transferrin receptor concentrations with age. Clin Chem 1999; 45: 1562–1563.
   Google Scholar
• Domellöf M, Lönnerdal B, Dewey KG, Cohen RJ, Rivera LL, Hernell O. Sex differences in iron status during infancy. Pediatrics 2002; 110: 545–552.
   PubMed Web of Science ®Google Scholar
• T’Sjoen GG, Beguin Y, Feyen E, Rubens R, Kaufman JM, Gooren L. Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. J Endocrinol 2005; 186: 61–67.
   Google Scholar
• Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005; 18: 319–331.
   PubMed Web of Science ®Google Scholar
• Thomas C, Kirschbaum A, Boehm D, Thomas L. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol 2006; 23: 23–36.
   Google Scholar
• Thomas C, Kobold U, Balan S, Roeddiger R, Thomas L.. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int J Lab Hematol 2010 Sep 27. doi: 10.1111/j.1751-553X.2010.01265.x. [Epub ahead of print].
   Google Scholar
• Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806–7810.
   PubMed Web of Science ®Google Scholar
• Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009; 113: 5277–5286.
   PubMed Web of Science ®Google Scholar
• Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, Hider RC, Koliaraki V, Mamalaki A, Olbina G, Tomosugi N, Tselepis C, Ward DG, Ganz T, Hendriks JC, Swinkels DW. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009; 94: 1748–1752.
   PubMed Web of Science ®Google Scholar
• Rouault TA, Rao K, Harford J, Mattia E, Klausner RD. Hemin, chelatable iron, and the regulation of transferrin receptor biosynthesis. J Biol Chem 1985; 260: 14862–14866.
   PubMedGoogle Scholar
• Baynes RD, Cook JD, Bothwell TH, Friedman BM, Meyer TE. Serum transferrin receptors in hereditary hemochromatosis and African siderosis. Am J Hematol 1994; 45: 288–292.
   Google Scholar
• Ledue TB, Craig WY. Serum concentrations of transferrin receptor in hereditary hemochromatosis. Clin Chem 1995; 41: 1053–1054.
   Google Scholar
• Centis F, Delfini C, Agostinelli F, Barbanti I, Annibali M, Lucarelli G. Correlation between soluble transferrin receptor and serum ferritin levels following bone marrow transplantation for thalassemia. Eur J Haematol 1995; 54: 329–333.
   Google Scholar
• Khumalo H, Gomo ZA, Moyo VM, Gordeuk VR, Saungweme T, Rouault TA, Gangaidzo IT. Serum transferrin receptors are decreased in the presence of iron overload. Clin Chem 1998; 44: 40–44.
   PubMed Web of Science ®Google Scholar
• Xiong S, She H, Sung CK, Tsukamoto H. Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol 2003; 30: 107–113.
   PubMed Web of Science ®Google Scholar
• Ohtake T, Saito H, Hosoki Y, Inoue M, Miyoshi S, Suzuki Y, Fujimoto Y, Kohgo Y. Hepcidin is down-regulated in alcohol loading. Alcohol Clin Exp Res 2007; 31 (1 Suppl): 2S–8S.
   Google Scholar
• Cylwik B, Chrostek L, Daniluk M, Koput A, Szmitkowski M. The assessment of serum soluble transferrin receptor in alcoholics. Clin Exp Med 2010; 10: 73–79.
   Google Scholar
• Soininen K, Punnonen K, Matinlauri I, Karhapää P, Rehu M. Transferrin receptor expression on reticulocytes as a marker of iron status in dialyzed patients. Clin Chem Lab Med 2010; 48: 1239–1245.
   Google Scholar
• Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217–222.
   PubMed Web of Science ®Google Scholar
• Ahluwalia N, Skikne BS, Savin V, Chonko A. Markers of masked iron deficiency and effectiveness of erythropoietin therapy in chronic renal failure. Am J Kidney Dis 1997; 30: 532–541.
   PubMed Web of Science ®Google Scholar
• Ervasti M, Kotisaari S, Romppanen J, Punnonen K. In patients who have stainable iron in the bone marrow an elevated plasma transferrin receptor value may reflect functional deficiency. Clin Lab Haematol 2004; 26: 205–209.
   PubMedGoogle Scholar
• Tarng D-C, Huang T-P. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patient. Nephrol Dial Transplant 2002; 17: 1063–1069.
   PubMed Web of Science ®Google Scholar
• Ervasti M, Matinlauri I, Punnonen K. Quantitative flow cytometric analysis of transferrin receptor expression on reticulocytes. Clin Chim Acta 2007; 383: 153–157.
   Google Scholar
• Coppo R, Feehally J, Glassock RJ. IgA nephropathy at two score and one. Kidney Int 2010; 77: 181–186.
   PubMed Web of Science ®Google Scholar
• Kerr MA. The structure and function of human IgA. Biochem J 1990; 271: 285–296.
   PubMed Web of Science ®Google Scholar
• Monteiro RC. Pathogenic role of IgA receptors in IgA nephropathy. Contrib Nephrol 2007; 157: 64–69.
   Google Scholar
• Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD, Monteiro RC. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001; 194: 417–425.
   PubMed Web of Science ®Google Scholar
• Haddad E, Moura IC, Arcos-Fajardo M, Macher MA, Baudouin V, Alberti C, Loirat C, Monteiro RC, Peuchmaur M. Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephritis: association between CD71 expression and IgA deposits. J Am Soc Nephrol 2003; 14: 327–337.
   PubMed Web of Science ®Google Scholar
• Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005; 16: 2667–2676.
   Google Scholar
• Monteiro RC, Moura IC, Launay P, Tsuge T, Haddad E, Benhamou M, Cooper MD, Arcos-Fajardo M. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 2002; 8: 464–468.
   Google Scholar
• Banfi G, Lombardi G, Colombini A, Lippi G. A world apart: inaccuracies of laboratory methodologies in antidoping testing. Clin Chim Acta 2010; 411: 1003–1008.
   PubMed Web of Science ®Google Scholar
• Gore CJ, Parisotto R, Ashenden MJ, Stray-Gundersen J, Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Hahn AG. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 2003; 88: 333–344.
   PubMed Web of Science ®Google Scholar
• Banfi G, Morelli P, Pacioni A, Graziani R, Freschi M, Cauci S. Soluble transferrin receptor values in top level soccer players and skiers: comparison with sedentary people and pitfalls of laboratory methods. J Sports Med Phys Fitness 2009; 49: 308–314.
   Google Scholar
• Thompson RJ Jr, Gustafson KE, Bonner MJ, Ware RE. Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol 2002; 27: 235–244.
   Google Scholar
• Singhal A, Cook JD, Skikne BS, Thomas P, Serjeant B, Serjeant G. The clinical significance of serum transferrin receptor levels in sickle cell disease. Br J Haematol 1993; 84: 301–304.
   PubMed Web of Science ®Google Scholar
• Serjeant G, Serjeant B, Stephens A, Roper D, Higgs D, Beckford M, Cook J, Thomas P. Determinants of haemoglobin level in steady-state homozygous sickle cell disease. Br J Haematol 1996; 92: 143–149.
   PubMed Web of Science ®Google Scholar
• Tancabelic J, Sheth S, Paik M, Piomelli S. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion. Am J Hematol 1999; 60: 121–125.
   Web of Science ®Google Scholar
• Lopez-Sall P, Diop PA, Diagne I, Cissé A, Mahou CM, Sylla-Niang M, Guéye PM, Diarra M. Transferrine soluble receptors’ contribution to the assessment of iron status in homozygous drepanocytic anemia. Ann Biol Clin (Paris) 2004; 62: 415–421.
   PubMed Web of Science ®Google Scholar
• Klemow D, Einsphar D, Brown TA, Flowers CH, Skikne BS. Serum transferrin receptor measurements in hematologic malignancies. Am J Hematol 1990; 34: 193–198.
   Google Scholar
• Binet JL, Lepoprier M, Dighiero G, Charron D, D’Athis P, Vaugier G, Beral HM, Natali JC, Raphael M, Nizet B, Follezou JY. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977; 40: 855–864.
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234.
   PubMed Web of Science ®Google Scholar
• Metzgeroth G, Schultheis B, Kuhn C, Dorn-Beineke A, LaRosée P, Hehlmann R, Hastka J. The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia. Clin Chem Lab Med 2007; 45: 1313–1318.
   PubMed Web of Science ®Google Scholar
• Phillips RE, Looareesuwan S, Warrell DA, Lee SH, Karbwang J, Warrell MJ, White NJ, Swasdichai C, Weatherall DJ. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986; 58: 305–323.
   PubMedGoogle Scholar
• Adelekan DA, Thurnham DI. Plasma ferritin concentrations in anaemic children: relative importance of malaria, riboflavin deficiency, and other infections. Am J Clin Nutr 1990; 51: 453–456.
   PubMed Web of Science ®Google Scholar
• Williams TN, Maitland K, Rees DC, Peto TE, Bowden DK, Weatherall DJ, Clegg JB. Reduced soluble transferrin receptor concentrations in acute malaria in Vanuatu. Am J Trop Med Hyg 1999; 60: 875–878.
   Google Scholar
• Kuvibidila S, Mark JA, Warrier RP, Yu L, Ode D, Tshefu KA. Soluble transferrin receptor as an index of iron status in Zairian children with malaria. J Trop Med Hyg 1995; 98: 373–378.
   Google Scholar
• Kasvosve I, Gomo ZA, Nathoo KJ, Matibe P, Mudenge B, Loyevsky M, Nekhai S, Gordeuk VR. Association of serum transferrin receptor concentration with markers of inflammation in Zimbabwean children. Clin Chim Acta 2006; 371: 130–136.
   Google Scholar
• Davis RJ, Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986; 261: 8708–8711.
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM, Moreno JM, López-Bermejo A, Chico B, Vendrell J, Ricart W. Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity. Diabetes Care 2007; 30: 604–608.
   PubMed Web of Science ®Google Scholar
• Fernández-Real JM, Izquierdo M, Moreno-Navarrete JM, Gorostiaga E, Ortega F, Martínez C, Idoate F, Ricart W, Ibañez J. Circulating soluble transferrin receptor concentration decreases after exercise-induced improvement of insulin sensitivity in obese individuals. Int J Obes (Lond) 2009; 33: 768–774.
   Google Scholar
• Tanner LI, Lienhard GE. Localization of transferrin receptors and insulin-like growth factor II receptors in vesicles from 3T3-L1 adipocytes that contain intracellular glucose transporters. J Cell Biol 1989; 108: 1537–1545.
   Google Scholar
• Lemieux K, Han XX, Dombrowski L, Bonen A, Marette A. The transferrin receptor defines two distinct contraction-responsive GLUT4 vesicle populations in skeletal muscle. Diabetes 2000; 49: 183–189.
   Google Scholar
• Salonen JT, Tuomainen TP, Nyyssönen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin-dependent diabetes in men: case-control study. Br Med J 1999; 317: 727–730.
   Google Scholar
• Lao TT CP, Tam KF. Gestational diabetes mellitus in the last trimester: a feature of maternal iron excess? Diabet Med 2001; 18: 218–223.
   Google Scholar
• Fernández-Real JM, Mercader JM, Ortega FJ, Moreno-Navarrete JM, López-Romero P, Ricart W. Transferrin receptor-1 gene polymorphisms are associated with type 2 diabetes. Eur J Clin Invest 2010; 40: 600–607.
   Google Scholar
• Hirayama M, Kohgo Y, Kondo H, Shintani N, Fujikawa K, Sasaki K, Kato J, Niitsu Y. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 1993;18: 874–880.
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86: 1154–1159.
   PubMed Web of Science ®Google Scholar
• Barthelemy C, Khalfoun B, Guillaumin JM, Lecomte P, Bardos P. Seminal fluid transferrin as an index of gonadal function in men. J Reprod Fert 1988; 82: 113–118.
   PubMedGoogle Scholar
• Holmes SD, Lipshultz LI, Smith RG. Transferrin and gonadal dysfunction in man. Fertil Steril 1982; 38: 600–604.
   PubMed Web of Science ®Google Scholar
• Skinner MK, Griswold MD. Secretion of testicular transferrin by cultured Sertoli cells is regulated by hormones and retinoids. Biol Reprod 1982; 27: 211–221.
   PubMed Web of Science ®Google Scholar
• Sylvester SR, Griswold MD. The testicular iron shuttle: a “nurse” function of the Sertoli cells. J Androl 1994; 15: 381–385.
   PubMed Web of Science ®Google Scholar
• Morales C, Sylvester SR. Griswold MD. Transport of iron and transferrin synthesis by the seminiferous epithelium of the rat in vivo. Biol Reprod 1987; 37: 995–1005.
   Google Scholar
• Vannelli BG, Orlando C, Barni T, Natali A, Serio M, Balboni GC. Immunostaining of transferrin and transferrin receptor in human seminiferous tubules. Fertil Steril 1986; 45: 536–541.
   PubMed Web of Science ®Google Scholar
• Orlando C, Caldini AL, Barni T, Wood WG, Strasburger CJ, Natali A, Maver A, Forti G, Serio M. Ceruloplasmin and transferrin in human seminal plasma: are they an index of seminiferous tubular function? Fert Steril 1985; 43: 290–294.
   PubMed Web of Science ®Google Scholar
• Foresta C, Manoni F, Businaro V, Donadel C, Indino M, Scandellari C. Possible significance of transferrin levels in seminal plasma of fertile and infertile men. J Androl 1986; 77: 77–82.
   Google Scholar
• Sylvester S, Griswold M. Molecular biology of iron transport in the testis. In: de Kretser D, ed. Molecular Biology of the Male Reproductive System. San Diego: Academic Press, 1993: 311–323.
   Google Scholar
• Ber A, Vardinon N, Yogev L, Yavetz H, Homonnai ZT, Yust I, Paz GF. Transferrin in seminal plasma and in serum of men: its correlation with sperm quality and hormonal status. Hum Reprod 1990; 5: 294–297.
   PubMed Web of Science ®Google Scholar
• Zalata A, Hafez T, Schoonjans F, Comhaire F. The possible meaning of transferrin and its soluble receptors in seminal plasma as markers of the seminiferous epithelium. Hum Reprod 1996; 11: 761–764.
   Google Scholar
• El Garem YF, Depuydt CE, El Arini AF, El Beheiry AH, Abou Zeid SA, Comhaire FH. Relationship between seminal plasma-soluble transferrin receptor and spermatogenesis in azoospermic patients. Fertil Steril 2003; 79 (Suppl3): 1668S–1669S.
   Google Scholar
• Mateos F, Brock JH, Perez-Arellano JL. Iron metabolism in the lower respiratory tract. Thorax 1998; 53: 594–600.
   PubMed Web of Science ®Google Scholar
• Krsek-Staples JA, Kew RR, Webster RO. Ceruloplasmin and transferrin levels are altered in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992; 145: 1009–1015.
   PubMed Web of Science ®Google Scholar
• Stites SW, Nelson ME, Wesselius LJ. Transferrin concentrations in serum and lower respiratory tract fluid of mechanically ventilated patients with COPD or ARDS. Chest 1995; 107:1681–1685.
   PubMed Web of Science ®Google Scholar
• Shigemura M, Nasuhara Y, Konno S, Hattori T, Shimizu C, Matsuno K, Nishimura M. Levels of transferrin in bronchoalveolar lavage fluid in sarcoidosis. Lung 2010; 188: 151–157.
   Google Scholar
• Popp W, Herkner K, Böck A, Rauscher H, Wanke T, Ritschka L, Zwick H. Influences of the cellular and humoral immune system in bronchoalveolar lavage on lung function in pulmonary sarcoidosis. Respiration 1992; 59: 89–93.
   Google Scholar
• Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990; 31: 1909–1914.
   PubMedGoogle Scholar
• Tsuchiya Y, Nakao A, Komatsu T, Yamamoto M, Shimokata K. Relationship between gallium 67 citrate scanning and transferrin receptor expression in lung diseases. Chest 1992; 102: 530–534.
   Google Scholar
• Haslam PL, Parker DJ, Townsend PJ. Increases in HLA DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosingalveolitis. Chest 1990; 97: 651–661.
   PubMed Web of Science ®Google Scholar
• Kondo K, Noguchi M, Mukai K, Matsuno Y, Sato Y, Shimosato Y, Monden Y. Transferrin receptor expression in adenocarcinoma of the lung as a histopathological indicator of prognosis. Chest 1990; 97: 1367–1371.
   PubMed Web of Science ®Google Scholar
• Vostrejs M, Moran PL and Seligman P. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation. J Clin Invest 1988; 82: 331–339.
   PubMed Web of Science ®Google Scholar
• Dowlati A, Loo M, Bury T, Fillet G, Beguin Y. Soluble and cell associated transferrin receptor in lung cancer. Br J Cancer 1997; 75: 1802–1806.
   PubMed Web of Science ®Google Scholar
• Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000; 37: 93–130.
   PubMed Web of Science ®Google Scholar
• Jayaranee S, Sthaneshwar P. RET-Y and RBC-Y in the diagnosis of iron deficiency associated with anaemia of inflammation. Int J Lab Hematol 2010; 32: 512–518.
   Google Scholar
• Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006; 1(Suppl1): S4–S8.
   Google Scholar
• Gupta S, Uppal B, Pawar B. Is soluble transferrin receptor a good marker of iron deficiency anemia in chronic kidney disease patients? Indian J Nephrol 2009; 19: 96–100.
   PubMedGoogle Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011–1023.
   PubMed Web of Science ®Google Scholar